BR9711627A - Derivados de cido propiÄnico e seu uso - Google Patents
Derivados de cido propiÄnico e seu usoInfo
- Publication number
- BR9711627A BR9711627A BR9711627A BR9711627A BR9711627A BR 9711627 A BR9711627 A BR 9711627A BR 9711627 A BR9711627 A BR 9711627A BR 9711627 A BR9711627 A BR 9711627A BR 9711627 A BR9711627 A BR 9711627A
- Authority
- BR
- Brazil
- Prior art keywords
- propionic acid
- acid derivatives
- derivatives
- propionic
- acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
- C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
- C07D213/20—Quaternary compounds thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP21754896A JP3215048B2 (ja) | 1996-04-03 | 1996-08-19 | プロピオン酸誘導体及びその用途 |
PCT/JP1997/002873 WO1998007699A1 (fr) | 1996-08-19 | 1997-08-19 | Derives d'acide propionique et applications de ces derives |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9711627A true BR9711627A (pt) | 1999-08-24 |
Family
ID=16705991
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9711627A BR9711627A (pt) | 1996-08-19 | 1997-08-19 | Derivados de cido propiÄnico e seu uso |
Country Status (17)
Country | Link |
---|---|
US (1) | US6204277B1 (pt) |
EP (1) | EP0930299A1 (pt) |
KR (1) | KR20000068151A (pt) |
CN (1) | CN1233241A (pt) |
AU (1) | AU740444B2 (pt) |
BG (1) | BG103268A (pt) |
BR (1) | BR9711627A (pt) |
CA (1) | CA2263721A1 (pt) |
CZ (1) | CZ53699A3 (pt) |
EE (1) | EE03765B1 (pt) |
IL (1) | IL128600A0 (pt) |
NO (1) | NO312160B1 (pt) |
NZ (1) | NZ334738A (pt) |
PL (1) | PL331861A1 (pt) |
RU (1) | RU2174121C2 (pt) |
SK (1) | SK21099A3 (pt) |
WO (1) | WO1998007699A1 (pt) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL121202A (en) | 1996-07-01 | 2001-08-26 | Lilly Co Eli | Hypoglycemic and hypolipidemic compounds, process for their preparation, pharmaceutial compositions comprising same, and uses thereof |
ATE268750T1 (de) * | 1997-08-28 | 2004-06-15 | Biovitrum Ab | Proteintyrosinphosphatase inhibitoren |
US6410585B1 (en) | 1997-08-28 | 2002-06-25 | Scott D. Larsen | Inhibitors of protein tyrosine phosphatase |
WO1999046232A1 (fr) | 1998-03-10 | 1999-09-16 | Ono Pharmaceutical Co., Ltd. | Derives d'acide carboxylique et medicaments contenant ces derives comme principe actif |
GB9817118D0 (en) * | 1998-08-07 | 1998-10-07 | Glaxo Group Ltd | Pharmaceutical compounds |
EP1140784A2 (en) * | 1998-12-22 | 2001-10-10 | Neurosearch A/S | Ion channel modulating agents |
GB9914977D0 (en) | 1999-06-25 | 1999-08-25 | Glaxo Group Ltd | Chemical compounds |
DK1206457T3 (da) | 1999-08-27 | 2004-02-16 | Lilly Co Eli | Biaryl-oxa(thia)zolderivater og deres anvendelse som modulatorer PPAP'ER |
JP4316787B2 (ja) * | 2000-01-11 | 2009-08-19 | 壽製薬株式会社 | エーテル又はアミド誘導体、その製法並びにそれを含有する糖尿病治療剤、 |
US6768008B2 (en) | 2000-04-24 | 2004-07-27 | Aryx Therapeutics | Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis |
US6680387B2 (en) | 2000-04-24 | 2004-01-20 | Aryx Therapeutics | Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis |
US6958355B2 (en) | 2000-04-24 | 2005-10-25 | Aryx Therapeutics, Inc. | Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis |
US7049342B2 (en) | 2000-05-29 | 2006-05-23 | Kyorin Pharmaceutical Co., Ltd. | Substituted phenylpropionic acid derivatives |
JP4803946B2 (ja) * | 2000-05-29 | 2011-10-26 | 杏林製薬株式会社 | 置換フェニルプロピオン酸誘導体 |
US6525095B1 (en) * | 2000-07-10 | 2003-02-25 | New Mexico State University Technology Transfer Corporation | Propionate feed supplement |
IL154110A0 (en) * | 2000-08-23 | 2003-07-31 | Lilly Co Eli | Oxazolyl-arylpropionic acid derivatives and their use as ppar agonists |
JP2004506722A (ja) | 2000-08-23 | 2004-03-04 | イーライ・リリー・アンド・カンパニー | ペルオキシソーム増殖因子活性化受容体の調節方法 |
EP1313715B1 (en) | 2000-08-23 | 2007-08-01 | Eli Lilly And Company | Oxazolyl-aryloxyacetic acid derivatives and their use as ppar agonists |
AU2001294673A1 (en) | 2000-09-21 | 2002-04-02 | Aryx Therapeutics | Isoxazolidine compounds useful in the treatment of diabetes, hyperlipidemia, andatherosclerosis |
GB0031109D0 (en) | 2000-12-20 | 2001-01-31 | Glaxo Group Ltd | Chemical compounds |
GB0113231D0 (en) * | 2001-05-31 | 2001-07-25 | Glaxo Group Ltd | Chemical compounds |
KR100474137B1 (ko) * | 2001-11-16 | 2005-03-08 | (주)바이오뉴트리젠 | 신규의 아릴프로피온산 유도체 및 이를 포함하는 당뇨병 예방 또는 치료용 조성물 |
KR100459917B1 (ko) * | 2001-12-14 | 2004-12-03 | (주)바이오뉴트리젠 | 페놀릭산 유도체 및 이를 포함하는 혈중 지질 농도 관련질환의 예방 및 치료용 조성물 |
ITRM20020016A1 (it) * | 2002-01-15 | 2003-07-15 | Sigma Tau Ind Farmaceuti | Derivati di acidi fenil(alchil)carbossilici e derivati fenilalchileterociclici dionici, loro uso come medicamenti ad attivita' ipoglicemizza |
US6933309B2 (en) * | 2002-01-17 | 2005-08-23 | Toaeiyo Ltd. | Halogenobenzyl aminopropionic acid derivatives |
US20050084840A1 (en) * | 2002-01-23 | 2005-04-21 | Hideki Endoh | Method for screening drug for improving insulin resistance |
ATE415160T1 (de) | 2002-02-25 | 2008-12-15 | Lilly Co Eli | Modulatoren von peroxisome proliferator- aktivierten rezeptoren |
EP1480640B1 (en) | 2002-02-25 | 2007-08-15 | Eli Lilly And Company | Peroxisome proliferator activated receptor modulators |
US20030207924A1 (en) * | 2002-03-07 | 2003-11-06 | Xue-Min Cheng | Compounds that modulate PPAR activity and methods of preparation |
US6833380B2 (en) | 2002-03-07 | 2004-12-21 | Warner-Lambert Company, Llc | Compounds that modulate PPAR activity and methods of preparation |
US6875780B2 (en) | 2002-04-05 | 2005-04-05 | Warner-Lambert Company | Compounds that modulate PPAR activity and methods for their preparation |
US6716842B2 (en) * | 2002-04-05 | 2004-04-06 | Warner-Lambert Company, Llc | Antidiabetic agents |
KR100474202B1 (ko) * | 2002-05-04 | 2005-03-08 | 강헌중 | 티아졸 유도체의 제조방법 및 이를 제조하기 위한 중간체 |
AU2003302111A1 (en) * | 2002-11-15 | 2004-06-15 | Cadila Healthcare Limited | Substituted aralkyl derivatives |
US7244763B2 (en) | 2003-04-17 | 2007-07-17 | Warner Lambert Company Llc | Compounds that modulate PPAR activity and methods of preparation |
US7037384B2 (en) * | 2003-06-23 | 2006-05-02 | Bulk Chemicals, Inc. | Lubricating chemical coating for metalworking |
CN100436430C (zh) * | 2004-05-24 | 2008-11-26 | 北京摩力克科技有限公司 | 作为hPPARα和hPPARγ激动剂的烷酰基取代的酪氨酸衍生物 |
CN101014595A (zh) * | 2004-08-11 | 2007-08-08 | 杏林制药株式会社 | 新型环状氨基苯甲酸衍生物 |
FR2882359A1 (fr) * | 2005-02-24 | 2006-08-25 | Negma Lerads Soc Par Actions S | Derives activateurs de ppar, procede de preparation et application en therapeutique |
FR2901792A1 (fr) * | 2006-06-06 | 2007-12-07 | Negma Lerads Soc Par Actions S | DERIVES ACTIVATEURS DE PPARs, PROCEDE DE PREPARATION ET APPLICATION EN THERAPEUTIQUE |
KR101497577B1 (ko) * | 2012-07-31 | 2015-03-02 | 서울대학교산학협력단 | 2-에톡시프로피온산 유도체 또는 이의 약학적으로 허용가능한 염을 유효성분으로 함유하는 일주기 연관성 질환의 예방 또는 치료용 약학적 조성물 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1003445B (zh) | 1984-10-03 | 1989-03-01 | 武田药品工业株式会社 | 噻唑烷二酮衍生物,其制备方法和用途 |
US5089514A (en) | 1990-06-14 | 1992-02-18 | Pfizer Inc. | 3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents |
HUT70153A (en) | 1990-08-23 | 1995-09-28 | Pfizer | Hypoglycemic hydroxyurea derivatives |
US5498621A (en) | 1992-05-01 | 1996-03-12 | Pfizer Inc. | Oxazolidinedione hypoglycemic agents |
GB9225386D0 (en) * | 1992-12-04 | 1993-01-27 | Smithkline Beecham Plc | Novel compounds |
TW268952B (pt) | 1993-02-26 | 1996-01-21 | Takeda Pharm Industry Co Ltd | |
JP3466273B2 (ja) * | 1993-06-11 | 2003-11-10 | 武田薬品工業株式会社 | テトラゾール誘導体、その製造法およびそれを含んでなる医薬 |
US5591862A (en) | 1993-06-11 | 1997-01-07 | Takeda Chemical Industries, Ltd. | Tetrazole derivatives, their production and use |
ATE179709T1 (de) * | 1993-12-27 | 1999-05-15 | Japan Tobacco Inc | Isoxazolidindionderivate und deren verwendung |
JPH08325263A (ja) * | 1995-05-31 | 1996-12-10 | Sumitomo Metal Ind Ltd | 新規2−アミノ−3−フェニルプロピオン酸誘導体 |
GB9604242D0 (en) | 1996-02-28 | 1996-05-01 | Glaxo Wellcome Inc | Chemical compounds |
IL121202A (en) | 1996-07-01 | 2001-08-26 | Lilly Co Eli | Hypoglycemic and hypolipidemic compounds, process for their preparation, pharmaceutial compositions comprising same, and uses thereof |
-
1997
- 1997-08-19 CZ CZ99536A patent/CZ53699A3/cs unknown
- 1997-08-19 SK SK210-99A patent/SK21099A3/sk unknown
- 1997-08-19 EE EEP199900069A patent/EE03765B1/xx not_active IP Right Cessation
- 1997-08-19 PL PL97331861A patent/PL331861A1/xx unknown
- 1997-08-19 AU AU38665/97A patent/AU740444B2/en not_active Ceased
- 1997-08-19 IL IL12860097A patent/IL128600A0/xx unknown
- 1997-08-19 EP EP97935823A patent/EP0930299A1/en not_active Withdrawn
- 1997-08-19 KR KR1019997001230A patent/KR20000068151A/ko not_active Application Discontinuation
- 1997-08-19 BR BR9711627A patent/BR9711627A/pt unknown
- 1997-08-19 RU RU99105567/04A patent/RU2174121C2/ru not_active IP Right Cessation
- 1997-08-19 NZ NZ334738A patent/NZ334738A/xx unknown
- 1997-08-19 WO PCT/JP1997/002873 patent/WO1998007699A1/ja not_active Application Discontinuation
- 1997-08-19 CA CA002263721A patent/CA2263721A1/en not_active Abandoned
- 1997-08-19 CN CN97198837A patent/CN1233241A/zh active Pending
- 1997-08-19 US US09/242,620 patent/US6204277B1/en not_active Expired - Fee Related
-
1999
- 1999-02-15 NO NO19990700A patent/NO312160B1/no unknown
- 1999-03-18 BG BG103268A patent/BG103268A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
EE03765B1 (et) | 2002-06-17 |
IL128600A0 (en) | 2000-01-31 |
AU740444B2 (en) | 2001-11-01 |
PL331861A1 (en) | 1999-08-16 |
NZ334738A (en) | 2001-01-26 |
WO1998007699A1 (fr) | 1998-02-26 |
NO312160B1 (no) | 2002-04-02 |
EP0930299A4 (pt) | 1999-07-21 |
US6204277B1 (en) | 2001-03-20 |
AU3866597A (en) | 1998-03-06 |
CN1233241A (zh) | 1999-10-27 |
NO990700L (no) | 1999-04-19 |
RU2174121C2 (ru) | 2001-09-27 |
CA2263721A1 (en) | 1998-02-26 |
CZ53699A3 (cs) | 1999-07-14 |
KR20000068151A (ko) | 2000-11-25 |
NO990700D0 (no) | 1999-02-15 |
BG103268A (en) | 2000-12-29 |
EE9900069A (et) | 1999-10-15 |
SK21099A3 (en) | 2000-05-16 |
EP0930299A1 (en) | 1999-07-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9711627A (pt) | Derivados de cido propiÄnico e seu uso | |
BR9708902A (pt) | Derivados de benzofurila e seu uso | |
CY2007020I2 (el) | Ορισμενα 5-αλκυλο-2-αρυλαμινοφαινυλοξικα οξεα και παραγωγα | |
DE69703385T2 (de) | Alkoxyessigsäure-derivate | |
NO990821D0 (no) | Arylsulfonylamino-hydroksaminsyre-derivater | |
FI953479A0 (fi) | 1-aryylipyrimidiinijohdannaiset ja niiden farmaseuttinen käyttö | |
BR9708894A (pt) | Derivados de acilmercapto-triazolila e seu uso como microbicidas | |
FI961599A (fi) | 1N-alkyyli-N-aryylipyrimidiiniamiineja ja niiden johdannaisia | |
DE69720051D1 (de) | Harnstoffderivate | |
DE69736579D1 (de) | Faltbare Wegwerfwindel | |
BR9703788A (pt) | Sulfonamidas e seu uso | |
FI955235A0 (fi) | Oksatsolidiinionijohdannaiset, niiden valmistus ja käyttö | |
BR9709107A (pt) | Derivados de tiocianato-triazolila e seu uso como microbicidas | |
BR9709258A (pt) | Derivados de sulfonil-mercaptotriazolila e seu uso como microbicidas | |
BR9704023A (pt) | Derivados de n-(4-aril)-tiazol-2-ila-sulfonamida e seu uso | |
IL126476A0 (en) | Aminoisoquinolines and aminothienopyridine derivatives and their use as anti-inflammatory agents | |
BR9707812A (pt) | Composto composto farmacêutica e uso do composto | |
NO985227D0 (no) | Alkylaminobenzothiazol og -benzoksazol - derivater | |
BR9703601A (pt) | Derivados de triazina e seu uso | |
DE69524611D1 (de) | Pyrimidon-derivate | |
BR9509641A (pt) | Sequências de dna e seu uso | |
DE69718338D1 (de) | 3-alkoxyisoxazol-4-yl-substituierte 2-aminocarbonsäurederivate | |
BR9709406A (pt) | Fluorenomas alquiloxiamino substituídas e seu uso como inibidores da proteína cinase-c | |
DK0826679T3 (da) | Naphthylforbindelser og -præparater | |
AU6120298A (en) | 2-peperazinone-1-acetic acid derivatives and their use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A E 8A ANUIDADES. |